HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012.

AbstractBACKGROUND:
Haiti had set a national goal to eliminate measles and rubella, as well as congenital rubella syndrome (CRS) by 2010. A 2007-2008 nationwide measles and rubella vaccination campaign targeting 1-19 years, however, reached only 79% of the target population. To assess whether population immunity was adequate to support elimination, we conducted a national serosurvey.
METHODS:
We systematically selected 740 serum specimens collected from pregnant women in a 2012 national antenatal HIV sentinel serosurvey across four age strata: 15-19, 20-24, 25-29 and 30-39 years. Sera were tested for measles and rubella specific immunoglobulin G antibodies (IgG) using commercial immunoassays. We classified sera as seropositive, seronegative or indeterminate per manufacturer's instructions, and analyzed seroprevalence according to age strata, and rural or urban residence. We assessed immunity by estimating antibody concentrations in international units per milliliter (IU/mL) for seropositive and indeterminate sera. Measles IgG concentrations >0.12 IU/mL and rubella IgG concentrations >10 IU/mL were considered clinically protective.
RESULTS:
Of 740 sera, 696 (94.1%) were seropositive and 20 (2.7%) were indeterminate for measles IgG; overall 716 (96.8%) sera had IgG concentrations >0.12 IU/mL. For rubella IgG, 691 (93.4%) sera were seropositive and 1 (0.1%) was indeterminate; a total of 687 (92.8%) had IgG concentrations >10 IU/mL. Measles seropositivity varied across age strata (p=0.003); seropositivity increased from 88.6% among 15-19 year olds to 98.4% among 30-39 year olds (Cochran-Armitage trend tes t ≤ 0.0001). Rubella seropositivity did not differ across age strata. There were no statistically significant differences in measles or rubella seropositivity by urban versus rural residence.
CONCLUSION:
Despite previous low vaccination coverage for measles, results from this serosurvey indicate high levels of measles and rubella seropositivity in pregnant women, and contribute to the evidence for measles, rubella and CRS elimination from Haiti by the target date.
AuthorsDavid L Fitter, Renette Anselme, Gilson Paluku, Gloria Rey, Brendan Flannery, Rania A Tohme, Barbara J Marston, Mark Griswold, Jacques Boncy, John F Vertefeuille
JournalVaccine (Vaccine) Vol. 32 Issue 1 Pg. 69-73 (Dec 17 2013) ISSN: 1873-2518 [Electronic] Netherlands
PMID24188751 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
CopyrightPublished by Elsevier Ltd.
Chemical References
  • Antibodies, Viral
  • Immunoglobulin G
  • Measles-Mumps-Rubella Vaccine
Topics
  • Adolescent
  • Adult
  • Antibodies, Viral (blood, immunology)
  • Female
  • Haiti (epidemiology)
  • Humans
  • Immunoglobulin G (blood, immunology)
  • Measles (epidemiology, immunology)
  • Measles-Mumps-Rubella Vaccine (immunology)
  • Pregnancy
  • Rubella (epidemiology, immunology)
  • Seroepidemiologic Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: